Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | APAF1 | O14727 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.52 |
| ▸ | FDPS | P14324 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PON1 | P27169 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4416367 | 0.97 | SMN1; SMN2 (0.55) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Hydrochloric Acid SCHEMBL4417695 | 0.97 | SMN1; SMN2 (0.50) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Iodide SCHEMBL4414352 | 0.97 | SMN1; SMN2 (0.50) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL6403529 | 0.84 | — | — | |
| SCHEMBL15136817 | 0.83 | SMN1; SMN2 (0.63) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL34729 | 0.81 | — | — | |
| Water SCHEMBL17764770 | 0.81 | SMN1; SMN2 (0.61) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Hydrogen Sulfide SCHEMBL16733052 | 0.79 | — | — | |
| SCHEMBL14499200 | 0.79 | — | — | |
| Water SCHEMBL409263 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303604-A1 | METALLIC TRANS-(N-HETEROCYCLIC CARBENE)-AMINE-PLATINUM COMPLEXES AND USES THEREOF FOR TREATING CANCER | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-09-28 | — | — | US | disclosed |
| US-20180079651-A1 | NOVEL METHODS FOR PRODUCING CRYSTALLINE MICROPOROUS SOLIDS WITH THE RTH TOPOLOGY AND COMPOSITIONS DERIVED FROM THE SAME | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2018-03-22 | — | — | US | disclosed |
| US-9908783-B2 | Methods for producing crystalline microporous solids with the RTH topology and compositions derived from the same | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-03-06 | — | — | US | disclosed |
| US-9873113-B2 | Methods for producing crystalline microporous solids with a new CIT-7 topology and compositions derived from the same | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-01-23 | — | — | US | disclosed |
| US-9861968-B2 | Methods for producing crystalline microporous solids with the HEU topology and compositions derived from the same | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-01-09 | — | — | US | disclosed |
| US-9782759-B2 | Methods for producing crystalline microporous solids with IWV topology and compositions derived from the same | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160369354-A1 | METHOD OF TARGETING MISMATCHED DNA USING d8 SQUARE PLANAR METAL COMPLEXES | THE UNIVERSITY OF HONG KONG (CN) | 2016-12-22 | — | — | US | disclosed |
| EP-2718394-B1 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND RADIATION EMITTING STRUCTURAL ELEMENT | OSRAM GMBH (DE) | 2015-08-26 | — | — | EP | disclosed |
| US-20150202603-A1 | NOVEL METHODS FOR PRODUCING CRYSTALLINE MICROPOROUS SOLIDS WITH THE HEU TOPOLOGY AND COMPOSITIONS DERIVED FROM THE SAME | NATIONAL SCIENCE FOUNDATION | 2015-07-23 | — | — | US | disclosed |
| US-20150203357-A1 | NOVEL METHODS FOR PRODUCING CRYSTALLINE MICROPOROUS SOLIDS WITH A NEW CIT-7 TOPOLOGY AND COMPOSITIONS DERIVED FROM THE SAME | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2015-07-23 | — | — | US | disclosed |
| EP-2718394-A1 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND RADIATION EMITTING STRUCTURAL ELEMENT | OSRAM GmbH (DE) | 2014-04-16 | — | — | EP | disclosed |
| US-20130164748-A1 | Detection of nucleic acid amplification | APPLIED BIOSYSTEMS LLC (US) | 2013-06-27 | — | — | US | disclosed |
| US-8247574-B2 | Use of PT -and PD-BIS- and tetra-carbon complexes with bridged carbon ligands in OLEDs | BASF SE (DE) | 2012-08-21 | — | — | US | disclosed |
| US-8247574-B2 | Use of PT -and PD-BIS- and tetra-carbon complexes with bridged carbon ligands in OLEDs | BASF SE (DE) | 2012-08-21 | — | — | US | disclosed |
| US-8247574-B2 | Use of PT -and PD-BIS- and tetra-carbon complexes with bridged carbon ligands in OLEDs | BASF SE (DE) | 2012-08-21 | — | — | US | disclosed |
| WO-2011000616-A1 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND RADIATION EMITTING STRUCTURAL ELEMENT | SIEMENS AKTIENGESELLSCHAFT (DE) | 2011-01-06 | — | — | WO | disclosed |
| US-20090326237-A1 | USE OF PT-AND PD-BIS-AND TETRA-CARBON COMPLEXES WITH BRIDGED CARBON LIGANDS IN OLEDS | BASF SE (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20090326237-A1 | USE OF PT-AND PD-BIS-AND TETRA-CARBON COMPLEXES WITH BRIDGED CARBON LIGANDS IN OLEDS | BASF SE (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20090326237-A1 | USE OF PT-AND PD-BIS-AND TETRA-CARBON COMPLEXES WITH BRIDGED CARBON LIGANDS IN OLEDS | BASF SE (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20070099211-A1 | Detection of nucleic acid amplification | APPLIED BIOSYSTEMS, LLC | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303604-A1 | METALLIC TRANS-(N-HETEROCYCLIC CARBENE)-AMINE-PLATINUM COMPLEXES AND USES THEREOF FOR TREATING CANCER | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MGMT, SLC11A2 | SMN1; SMN2 2061/4885MEN1 20/4885APAF1 2689/4885 |
| US-20180079651-A1 | NOVEL METHODS FOR PRODUCING CRYSTALLINE MICROPOROUS SOLIDS WITH THE RTH TOPOLOGY AND COMPOSITIONS DERIVED FROM THE SAME | TREH, SIN3A, HNRNPH3 | SMN1; SMN2 2376/4885MEN1 1554/4885APAF1 2933/4885 |
| US-20150202603-A1 | NOVEL METHODS FOR PRODUCING CRYSTALLINE MICROPOROUS SOLIDS WITH THE HEU TOPOLOGY AND COMPOSITIONS DERIVED FROM THE SAME | HNRNPU, STOM, SPOUT1 | SMN1; SMN2 3205/4885MEN1 344/4885APAF1 2151/4885 |
| US-20090326237-A1 | USE OF PT-AND PD-BIS-AND TETRA-CARBON COMPLEXES WITH BRIDGED CARBON LIGANDS IN OLEDS | PDCD1, PDCD1LG2, CD274 | SMN1; SMN2 4711/4885MEN1 3251/4885APAF1 3107/4885 |
| US-20150203357-A1 | NOVEL METHODS FOR PRODUCING CRYSTALLINE MICROPOROUS SOLIDS WITH A NEW CIT-7 TOPOLOGY AND COMPOSITIONS DERIVED FROM THE SAME | CA7, MCM7, IPO7 | SMN1; SMN2 3972/4885MEN1 398/4885APAF1 2131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.